Molecular Pathways Underlying Cardiac Remodeling During Pathophysiological Stimulation

被引：475

作者：

Kehat, Izhak ^{[1
]}

Molkentin, Jeffery D. ^{[1
,2
]}

机构：

[1] Univ Cincinnati, Cincinnati Childrens Hosp, Dept Pediat, Cincinnati, OH 45229 USA

[2] Howard Hughes Med Inst, Med Ctr, Cincinnati, OH 45229 USA

来源：

CIRCULATION | 2010年 / 122卷 / 25期

基金：

美国国家卫生研究院;

关键词：

ATRIAL-NATRIURETIC-PEPTIDE; ENDOTHELIAL GROWTH-FACTOR; HEART-FAILURE; MYOCARDIAL-INFARCTION; PRESSURE-OVERLOAD; TARGETED DELETION; IN-VIVO; VENTRICULAR ENLARGEMENT; HYPERTROPHIC RESPONSE; CLINICAL-IMPLICATIONS;

D O I：

10.1161/CIRCULATIONAHA.110.942268

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2727 / 2735

页数：9

共 81 条

[1] CaMKII and a failing strategy for growth in heart [J].

Anderson, Mark E. .

JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (05) :1082-1085

[2]

ANVERSA P, 1991, AM J CARDIOL, V68, pD7

[3] The δ isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload [J].

Backs, Johannes ;

Backs, Thea ;

Neef, Stefan ;

Kreusser, Michael M. ;

Lehmann, Lorenz H. ;

Patrick, David M. ;

Grueter, Chad E. ;

Qi, Xiaoxia ;

Richardson, James A. ;

Hill, Joseph A. ;

Katus, Hugo A. ;

Bassel-Duby, Rhonda ;

Maier, Lars S. ;

Olson, Eric N. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (07) :2342-2347

[4] Molecular regulation of cardiac hypertrophy [J].

Barry, Sean P. ;

Davidson, Sean M. ;

Townsend, Paul A. .

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2008, 40 (10) :2023-2039

[5] Pathological and physiological hypertrophies are regulated by distinct gene programs [J].

Beisvag, Vidar ;

Kemi, Ole Johan ;

Arbo, Ingerid ;

Loennechen, Jan Pal ;

Wisloff, Ulrik ;

Langaas, Mette ;

Sandvik, Arne Kristian ;

Ellingsen, Oyvind .

EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2009, 16 (06) :690-697

[6] Putting the brakes on cardiac hypertrophy - Exploiting the NO-cGMP counter-regulatory system [J].

Booz, GW .

HYPERTENSION, 2005, 45 (03) :341-346

[7] NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure [J].

Bourajjaj, Meriem ;

Armand, Anne-Sophie ;

Martins, Paula A. da Costa ;

Weijts, Bart ;

van der Nagel, Roel ;

Heeneman, Sylvia ;

Wehrens, Xander H. ;

De Windt, Leon J. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (32) :22295-22303

[8]

BRAUNWALD E, 1991, AM J CARDIOL, V68, pD1

[9] PKC-α regulates cardiac contractility and propensity toward heart failure [J].

Braz, JC ;

Gregory, K ;

Pathak, A ;

Zhao, W ;

Sahin, B ;

Klevitsky, R ;

Kimball, TF ;

Lorenz, JN ;

Nairn, AC ;

Liggett, SB ;

Bodi, I ;

Wang, S ;

Schwartz, A ;

Lakatta, EG ;

DePaoli-Roach, AA ;

Robbins, J ;

Hewett, TE ;

Bibb, JA ;

Westfall, MV ;

Kranias, EG ;

Molkentin, JD .

NATURE MEDICINE, 2004, 10 (03) :248-254

[10] Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NEAT signaling [J].

Braz, JC ;

Bueno, OF ;

Liang, QR ;

Wilkins, BJ ;

Dai, YS ;

Parsons, S ;

Braunwart, J ;

Glascock, BJ ;

Klevitsky, R ;

Kimball, TF ;

Hewett, TE ;

Molkentin, JD .

JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (10) :1475-1486

← 1 2 3 4 5 6 7 8 9 →